Adenosine Receptor Agonists Differentially Regulate IL-10, TNF-α, and Nitric Oxide Production in RAW 264.7 Macrophages and in Endotoxemic Mice

Journal of Immunology

Volumn 157, Issue 10, 1996, Pages 4634-4640

  Haskó, György ^a   Szabó, Csaba ^a,b   Németh, Zoltán H ^a   Kvetan, Vladimir ^c   Pastores, Stephen McCarthy ^c   Vizi, E Sylvester ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO N(6)CYCLOPENTYLADENOSINE; 2-CHLORO-N(6)CYCLOPENTYLADENOSINE; ADENOSINE; ADENOSINE RECEPTOR; DRUG DERIVATIVE; INTERLEUKIN 10; N(6) (3 IODOBENZYL) 5' N METHYLCARBOXAMIDOADENOSINE; N(6)-(3-IODOBENZYL)-5'-N-METHYLCARBOXAMIDOADENOSINE; NITRIC OXIDE; PHENETHYLAMINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENDOTOXEMIA; IMMUNOLOGY; MACROPHAGE; MALE; METABOLISM; MOUSE; PHYSIOLOGY;

ADENOSINE; ANIMALS; ENDOTOXEMIA; INTERLEUKIN-10; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; PHENETHYLAMINES; RECEPTORS, PURINERGIC P1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030588630     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Beutler, B. 1995. TNF, immunity and inflammatory disease: lessons of the past decade. J. Invest. Med. 43:227.
2. Szabó, C. 1995. Alterations in the production of nitric oxide in various forms of circulatory shock. New Horiz. 3:2.
3. Mosmann, T. R. 1994. Properties and functions of interleukin-10. Adv. Immunol. 56:1.
4. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815.
5. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
6. Barsig, J., S. Küsters, K. Vogt, H.-D. Volk, G. Tiegs, and A. Wendel. 1995. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-α. Eur. J. Immunol. 25:2888.
7. Gazzinelli, R. T., I. P. Oswald, S. L. James, and A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J. Immunol. 148:1792.
8. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin-10. J. Exp. Med. 174:1549.
9. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor-α and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547.
10. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205.
11. Chaudry, I. H., K. A. Wichtermann, and A. E. Baue. 1979. Effect of sepsis on tissue adenine nucleotide levels. Surgery 85:205.
12. Jabs, C. M., P. Neglen, and B. Eklof. 1995. Breakdown of adenine nucleotides, formation of oxygen free radicals, and early markers of cellular injury in endotoxic shock. Eur. J. Surg. 161:147.
13. Cronstein, B. N., S. B. Kramer, G. Weissman, and R. Hirschhorn. 1983. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J. Exp. Med. 158:1160.
14. Jurgensen, C. H., B. E. Huber, T. P. Zimmerman, and G. Wolberg. 1990. 3-deazaadenosine inhibits leukocyte adhesion and ICAM-1 biosynthesis in tumor necrosis factor-stimulated human endothelial cells. J. Immunol. 144:653.
15. Rose, F. R., R. Hirschorn, G. Weissmann, and B. N. Cronstein. 1988. Adenosine promotes neutrophil chemotaxis. J. Exp. Med. 167:1186.
16. 1 receptors. J. Immunol. 151:2775.
17. Eppel, B. A., A. M. Newell, and E. J. Brown. 1989. Adenosine receptors are expressed during differentiation of monocytes to macrophages in vitro. J. Immunol. 143:4141.
18. 3 receptor. Drug Dev. Res. 37:145.
19. Leonard, E. J., and A. Skeel. 1978. The action of the adenosylhomocisteine hydrolase inhibitor, 3-deazaadenosine, on phagocytic function of mouse macrophages and human monocytes. Biochem. Biophys. Res. Commun. 84:102.
20. Hon, W. M., H. H. Khoo, S. S. Ngoi, and S. Moochala. 1995. Effects of adenosine receptor agonists on nitric oxide release in mouse during endotoxaemia. Biochem. Pharmacol. 50:45.
21. Aksamit, R. R., P. S. Backlund, Jr., and G. L. Cantoni. 1983. Chemotaxis and the synthesis of specific proteins are inhibited by 3-deazaadenosine and other adenosine analogs in a mouse macrophage cell line. J. Biol. Chem. 258:20.
22. Lappin, D., and K. Whaley. 1984. Adenosine A2 receptors on human monocytes modulate C2 production. Clin. Exp. Immunol. 57:454.
23. + antigen expression. J. Leukocyte Biol. 56:133.
24. Bouma, M. G., R. K. Stad, F. A. van den Wildenberg, and W. A. Buurman. 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153:4159.
25. Parmely, M. J., W. W. Zhou, C. K. Edwards III, D. R. Borcherding, R. Silverstein, and D. C. Morrison. 1993. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge. J. Immunol. 151:389.
26. Le Vraux, V., Y. L. Chen, I. Masson, M. De Sousa, J. P. Giroud, I. Florentin, and L. Chauvelot-Moachon. 1993. Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci. 52:1917.
27. Prabhakar, U., D. P. Brooks, D. Lipshlitz, and K. M. Esser. 1995. Inhibition of LPS-induced TNF alpha production in human monocytes by adenosine (A2) receptor selective agonists. Int. J. Immunopharmacol. 17:221.
28. Sajjadi, F. G., K. Tabayashi, A. C. Foster, R. C. Domingo, and G. S. Firestein. 1996. Inhibition of TNF-α expression by adenosine: role of A3 adenosine receptors. J. Immunol. 156:3435.
29. Le Moine, O, P. Stordeur, L. Schandené, A. Marchant, D. de Groote, M. Goldman, and J. Deviere. 1996. Adenosine enhances IL-10 secretion by human monocytes. J. Immunol. 156:4408.
30. Müller, J. M., H. W. L. Ziegler-Heitbrock, and P. A. Bauerle. 1993. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187: 233.
31. Szabó, C., C. Thiemermann, and J. R. Vane. 1993. Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Biochem. Biophys. Res. Commun. 196:825.
32. Hassanain, H. H., W. Dai, and S. L. Gupta. 1993. Enhanced gel mobility shift assay for DNA-binding factors. Anal. Biochem. 213:162.
33. Szabó, C., C. C. Wu, J. A. Mitchell, S. S. Gross, C. Thiemermann, and J. R. Vane. 1993. Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ. Res. 73:991.
34. Szabó, C., C. C. Wu, S. S. Gross, C. Thiemermann, M. Perretti, and J. R. Vane. 1993. Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. Eur. J. Pharmacol. 250:157.
35. Thiemermann, C., C. C. Wu, C. Szabó, M. Perretti, and J. R. Vane. 1993. Tumour necrosis factor is an endogenous mediator of the induction of nitric oxide synthase in endotoxin shock in the rat. Br. J. Pharmacol. 110:177.
36. Cunha, F. Q., J. Assreuy, D. W. Moss, D. Rees, L. M. Leal, S. Moncada, M. Carrier, C. A. O'Donnell, and F. Y. Liew. 1994. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology 81:211.
37. Schneemann, M., G. Schoedon, K. Frei, and A. Schaffner. 1993. Immunovascular communication: activation and deactivation of murine endothelial cell nitric oxide synthase by cytokines. Immunol. Lett. 35:159.
38. Chesrown, S. E., J. Monnier, G. Visner, and H. S. Nick. 1994. Regulation of inducible nitric oxide synthase mRNA levels by LPS, IFN-gamma, TGF-beta, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 200:126.
39. Corradin, S. B., N. Fasel, Y. Buchmuller-Rouiller, A. Ransijn, J. Smith, and J. Mauel. 1993. Induction of macrophage nitric oxide production by interferon-gamma and tumor necrosis factor-alpha is enhanced by interleukin-10. Eur. J. Immunol. 23:2045.
40. Perretti, M., C. Szabó, and C. Thiemermann. 1995. Effect of interleukin-4 and interleukin-10 on leukocyte migration and the induction of nitric oxide synthase in vivo. Br. J. Pharmacol. 116:2251.
41. 2. J. Exp. Med. 180: 2365.
42. van der Poll, T., S. M. Coyle, K. Barbosa, C. C. Braxton, and S. F. Lowry. 1996. Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest. 97:713.
43. Platzer, C., Ch. Meisel, K. Vogt, M. Platzer, and H.-D. Volk. 1995. Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol. 7:517.
44. Arai, T., K. Hiromatsu, N. Kobayashi, M. Takano, H. Ishida, Y. Nimura, and Y. Yoshikai. 1995. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J. Immunol. 155:5743.
45. + thymocytes in vivo by anti-CD3 or 5′-(N-ethyl)-carboxamido-adenosine is blocked by glucocorticoid receptor agonist RU-486. Eur. J. Immunol. 23:1246.
46. Wanidworanun, C., and W. Strober. 1993. Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J. Immunol. 151:6853.
47. Szabó, C., B. Zingarelli, M. O'Connor, and A. L. Salzman. 1996. DNA strand breakage, activation of poly-ADP ribosyl synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc. Natl. Acad. Sci. USA 93:1753.
48. Szabó, C., B. J. Day, and A. L. Salzman. 1996. Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages, using a novel mesoporphyrin superoxide dismutase analog and peroxynitrite scavenger. FEBS Lett. 381:82.
49. Zingarelli, B., M. O'Connor, H. Wong, A. L. Salzman, and C. Szabó. 1996. Peroxynitrite-mediated DNA strand breakage activates poly-ADP ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J. Immunol. 156:350.
50. Frankenberger, M., A. Pforte, T. Sternsdorf, B. Passlick, P. A. Bauerle, and H. W. L. Ziegler-Heitbrock. 1994. Constitutive NF-κB in cells of the monocyte lineage. Biochem. J. 304:87.
51. Kim, J. M., C. I. Brannan, N. G. Copeland, N. A. Jenkins, T. A. Khan, and K. W. Moore. 1992. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J. Immunol. 148:3618.
52. Dalziel, H. H., and D. P. Westfall. 1994. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol. Rev. 46:449.
53. Olsson, R. A., and J. D. Pearson. 1990. Cardiovascular purinoceptors. Pharmacol. Rev. 70:761.
54. Hotchkiss, R. S., D. F. Osborne, G. D. Lappas, and I. E. Karl. 1995. Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor-α, interleukin-1β, and interleukin-1α in a mouse model of endotoxin. Shock 3:337.
55. Zhou, Q. Y., C. Li, M. E. Olah, R. A. Johnson, G. L. Stiles, and O. Civelli. 1992. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc. Natl. Acad. Sci. USA 89:7432.
56. 2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265:C577.
57. Vizi, E. S., B. Sperlágh, and M. Baranyi. 1992. Evidence that ATP, released from the postsynaptic site by noradrenaline, is involved in mechanical responses of guinea-pig vas deferens: cascade transmission. Neuroscience 50:455.
58. Sperlágh, B., and E. S. Vizi. 1996. Neuronal synthesis, storage and release of ATP. Semin. Neurosci. 8:175.
59. Proctor, R. A., L. C. Denlinger, P. S. Leventhal, S. K. Daugherty, J.-W. van de Loo, T. Tanke, G. S. Firestein, and P. J. Bertics. 1994. Protection of mice from endotoxic death by 2-methylthio-ATP. Proc. Natl. Acad. Sci. USA 91:6017.
60. Denlinger, L. C., P. L. Fisette, K. A. Garis, G. Kwon, A. Vazquez-Torres, A. D. Simon, B. Nguyen, R. A. Proctor, P. J. Bertics, and J. A. Corbett. 1996. Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J. Biol. Chem. 271:337.
61. Cronstein, B. N., M. A. Eberle, H. E. Gruber, and R. I. Levin. 1991. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc. Natl. Acad. Sci. USA 88:2441.
62. Cronstein, B. N., D. Naime, and E. Ostad. 1993. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92:2675.
63. Gadangi, P., M. Longaker, D. Naime, R. I. Levin, P. A. Recht, M. C. Montesinos, M. T. Buckley, G. Carlin, and B. N. Cronstein. 1996. The antiinflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J. Immunol. 156:1937.
64. Firestein, G. S., D. Boyle, D. A. Bullough, H. E. Gruber, F. G. Sajjadi, A. Montag, B. Sambol, and K. M. Mullane. 1994. Protective effect of an adenosine kinase inhibitor in septic shock. J. Immunol. 152:5853.
65. Cronstein, B. N., D. Naime, and G. Firestein. 1995. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum. 38:1040.
66. Rosengren, S., G. W. Bong, and G. S. Firestein. 1995. Anti-inflammatory effects of an adenosine kinase inhibitor: decreased neutrophil accumulation and vascular leakage. J. Immunol. 154:5444.
67. Firestein, G. S., D. A. Bullough, M. D. Erion, R. Jimenez, M. Ramirez-Weinhouse, J. Barankiewicz, C. W. Smith, H. E. Gruber, and K. M. Mullane. 1995. Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor: the role of selectins. J. Immunol. 154:326.
68. Pastures, S. M., G. Hasko, E. S. Vizi, and V. Kvetan. 1996. The role of vasoactive drugs in the regulation of cytokine production in sepsis. New Horiz. 4:252.